ArticleThe Journal of clinical endocrinology and metabolism2026
Gestational Diabetes Mellitus and Risk of Selected Cancers: A Danish National Register-based Cohort Study.
Article in The Journal of clinical endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gestational Diabetes Mellitus and Risk of Selected Cancers: A Danish National Register-based Cohort Study.The Journal of clinical endocrinology and metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
contextGestational diabetes mellitus (GDM) is the most common medical complication of pregnancy and is associated with type 2 diabetes, which is associated with breast cancer and kidney cancer. However, little is known about the risk of cancer following a GDM diagnosis.
objectiveThis study aimed to test the hypothesis that a history of GDM associates with increased risk of breast, gynecological, thyroid, and kidney cancer.
methodsNational cohort study, based on Danish registry data. The study population included a group of women exposed to GDM in their pregnancy leading to delivery between 2000 and 2019 or 1978 and 1997 and a 1:10 matched nonexposed group, matched on calendar period of delivery, the woman´s age (birth year), and the woman´s registered region of residence at delivery. Poisson regression adjusting for educational level was conducted.
resultsOf the 314 742 deliveries included, 28 613 deliveries were in the exposed group and 286 129 in the nonexposed. The median follow-up time was 8.1 years. We found no increased risk of the selected cancers combined [adjusted incidence rate ratio (aIRR) 1.05; 95% confidence interval (CI), 0.94-1.18], breast cancer (aIRR 1.02; 95% CI, 0.89-1.17), gynecological cancer (aIRR 1.00; 95% CI, 0.79-1.26), or thyroid cancer (aIRR 1.26; 95% CI, 0.86-1.82). However, an increased risk of kidney cancer was seen in women with previous GDM compared with women without GDM (aIRR 1.92; 95% CI, 1.10-3.33), although it was a very small absolute risk.
conclusionNo elevated risk was found for the selected cancers combined. Women with previous GDM had an increased risk of kidney cancer, a rare cancer form.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.